LAMEA Molecular Diagnostics Market (2016 - 2022)

LAMEA Molecular Diagnostics Market (2016 - 2022)

  • February 2017 •
  • 130 pages •
  • Report ID: 4770746
Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.

Rise in the incidence of chronic & infectious diseases and technological advancements is leading the market for molecular diagnostics market in LAMEA. According to the report by Avert in 2016, In Latin America, 1.6 people and In Brazil 830,000 peoples are dealing with HIV. Considering Middle East, studies stated that Middle East is a region with highest number of breast cancer cases and diseases. And the most effected population is the women under 60. In Addition, doctors have also stated the people are still unaware about the health issues in U.A.E and it is leading towards increase in infectious diseases.
The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region.

Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers.

Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.
The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region.

Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers.

Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.

Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers.

Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes.

Based on Country, market is segmented into Brazil, Argentina, UAE, Saudia Arabia, South Africa, Nigeria and Rest of LAMEA.

The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report include Abbott Laboratories, Qiagen N.V, Roche Diagnostics, Grifols, Siemens Healthcare (Siemens AG), Becton Dickinson and Company and Danaher Corporation.
Country=Brazil Industry=InVitroDiagnostics ParentIndustry=LifeSciences Date=201702 Topic=MarketSize Publisher=KBVResearch Price=2000